Seese Felix Kurt, Roscher Pia, Coppers Birte, Greenfield Julia, Grahammer Manuel, Kuhn Sebastian, Gupta Latika, Schett Georg, Knitza Johannes, Liphardt Anna-Maria
Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Ulmenweg 18, 91054, Erlangen, Germany.
Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Arthritis Res Ther. 2025 Feb 22;27(1):38. doi: 10.1186/s13075-025-03504-z.
Manual muscle testing (MMT8), the current gold standard for assessing muscle function in patients with idiopathic inflammatory myopathies (IIM), has notable limitations. This study had three aims (1) to compare MMT8 with inertial sensor-based gait analysis, (2) to evaluate patient-performed functional tests guided by shared decision-making (SDM), and (3) to investigate adherence to electronic patient-reported outcomes (ePROs).
Gold standard muscle function assessment (MMT8) was performed at baseline (T0) and three months (T1). Additionally, inertial-sensor-based gait analysis was completed at T0 and two standardized upper extremity (Modified Barré test; 10-time arm lift test) and two lower extremity muscle endurance tests (60-second Sit-to-Stand (STS) test; Mingazzini test) were presented to patients to choose from. Through shared decision-making, each patient selected one test for lower and upper extremities and opted to record weekly results on paper or through a medical app. Correlations between gait parameters, functional tests, and MMT8 were analyzed, while agreement between patient- and healthcare professional (HCP)-recorded results at T0 and T1 was assessed. Responsiveness to change was also evaluated.
A total of 28 IIM patients (67.9% female; mean age 57.4 ± 12.9 years) were enrolled. Moderate correlations were observed between gait parameters and MMT8, such as walking speed (r = 0.545, p = 0.004) and stride length (r = 0.580, p = 0.002). All patients selected the Modified Barré test for assessing upper extremity function and 60.7% of patients chose the Mingazzini test for lower extremity function. Agreement between patient- and HCP-recorded functional test results was excellent at baseline and after three months (ICC 0.99-1.00). Functional tests demonstrated strong correlations with MMT8, particularly for the Mingazzini test (r = 0.762, p = 0.002). Patients preferred app-based recording (82.1%) over paper-based methods and weekly ePROs were completed on average 6.9 out of 12 weeks (57.5%).
Patient-performed functional tests are reliable, scalable alternatives to MMT8, with gait analysis providing complementary insights. Digitally supported self-assessments can enhance clinical workflows, remote monitoring, and treat-to-target strategies, empowering patients and improving disease management.
徒手肌力测试(MMT8)是目前评估特发性炎症性肌病(IIM)患者肌肉功能的金标准,但存在明显局限性。本研究有三个目的:(1)比较MMT8与基于惯性传感器的步态分析;(2)评估在共同决策(SDM)指导下患者自行进行的功能测试;(3)调查对电子患者报告结局(ePROs)的依从性。
在基线(T0)和三个月(T1)时进行金标准肌肉功能评估(MMT8)。此外,在T0时完成基于惯性传感器的步态分析,并向患者提供两项标准化上肢测试(改良巴雷试验;10次上肢举起试验)和两项下肢肌肉耐力测试(60秒坐立试验;明加齐尼试验)供其选择。通过共同决策,每位患者为上下肢各选择一项测试,并选择通过纸质记录或医疗应用程序记录每周结果。分析步态参数、功能测试与MMT8之间的相关性,同时评估患者和医护人员(HCP)在T0和T1记录结果之间的一致性。还评估了对变化的反应性。
共纳入28例IIM患者(女性占67.9%;平均年龄57.4±12.9岁)。观察到步态参数与MMT8之间存在中度相关性,如步行速度(r = 0.545,p = 0.004)和步幅(r = 0.580,p = 0.002)。所有患者选择改良巴雷试验评估上肢功能,60.7%的患者选择明加齐尼试验评估下肢功能。患者和HCP记录的功能测试结果在基线和三个月后一致性极佳(组内相关系数ICC为0.99 - 1.00)。功能测试与MMT8显示出强相关性,尤其是明加齐尼试验(r = 0.762,p = 0.002)。患者更喜欢基于应用程序的记录方式(82.1%)而非纸质记录方式,在12周内平均完成了6.9周(57.5%)的每周ePROs。
患者自行进行的功能测试是MMT8可靠、可扩展的替代方法,步态分析可提供补充性见解。数字化支持的自我评估可改善临床工作流程、远程监测和达标治疗策略,增强患者能力并改善疾病管理。